| 发明名称 |
SUSTAINED RELEASE FORMULATION COMPRISING A CELLULOSIC POLYMER MATRIX AND GEPIRONE |
| 摘要 |
Pharmaceutical compsn. for making oral extended release gepirone (I) dosage forms comprises: (a) 0.5-12 wt.% (I).HCl; (b) 70-85 wt.% cellulosic polymer matrix; (c) excipients. The release rate of (I) is such that 18-24 hrs. are required to attain 90-95% absorption of (I). Pref. (b) is hydroxypropylmethylcellulose with viscosity 1.5 x 104 - 1 x 106; and (c) is colourant, microcrystalline cellulose, colloidal silica and/or magnesium stearate.
|
| 申请公布号 |
NZ272855(A) |
申请公布日期 |
1997.05.26 |
| 申请号 |
NZ19950272855 |
申请日期 |
1995.08.25 |
| 申请人 |
BRISTOL-MYERS SQUIBB CO |
发明人 |
DAVID, STEPHEN T;GALLIAN, CLAUDE E;CHOU, JOSEPH C H |
| 分类号 |
A61K9/22;A61K9/00;A61K9/20;A61K9/26;A61K9/50;A61K9/52;A61K31/505;A61K31/506;A61K47/02;A61K47/12;A61K47/38;A61P25/20;A61P25/22;A61P25/24;A61P25/26;(IPC1-7):A61K31/505;A61K9/16 |
主分类号 |
A61K9/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
